×
-0.0105100463678517 -0.0105100463678517 -0.00301081916537868 -0.000463678516228766 -0.0051004636785162 0.0017032457496137 -0.00540958268933531 0.0115486862442041
Stockreport

PTC to commercialize two Akcea drugs in Latin America [Seeking Alpha]

AKCEA THERAPEUTICS (AKCA)  More Company Research Source: Seeking Alpha
Last akcea therapeutics earnings: 8/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.akceatx.com/media-investors/press-releases
PDF Akcea Therapeutics ( AKCA ) inks an agreement with PTC Therapeutics ( PTCT ) under which the latter will commercialize TEGSEDI (inotersen) and WAYLIVRA (volanesorsen) in Latin America. Under the terms of the deal, PTC has exclusive rights to the two products in Latin America and certain Caribbean countries. Akcea will receive $12M upfront, $6M upon FDA or EMA approval of WAYLIVRA and mid-twenties royalties on net sales. Ionis Pharmaceuticals ( IONS ) receive 60% of all monies paid to Akcea from TEGSEDI and 50% of the monies from WAYLIVRA. TEGSEDI is indicated for stage 1 or 2 polyneuropathy in adult patients with hereditary transthyretin amyloidosis. WAYLIVRA is indicated for familial chylomicronemia syndrome. Click to subscribe to real-time analytics on AKCA Now read: Akcea Therapeutics: What The EU Tegsedi Approval Foretells » Subscribe for full text news in your inbox [Read more]

IMPACT SNAPSHOT EVENT TIME: AKCA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AKCA alerts

from News Quantified
Opt-in for
AKCA alerts

from News Quantified